Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Fortress Biotech (FBIO) Net Income towards Common Stockholders (2016 - 2025)

Fortress Biotech has reported Net Income towards Common Stockholders over the past 13 years, most recently at -$6.2 million for Q4 2025.

  • Quarterly results put Net Income towards Common Stockholders at -$6.2 million for Q4 2025, up 35.79% from a year ago — trailing twelve months through Dec 2025 was -$1.9 million (up 96.63% YoY), and the annual figure for FY2025 was -$1.9 million, up 96.63%.
  • Net Income towards Common Stockholders for Q4 2025 was -$6.2 million at Fortress Biotech, down from $3.7 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for FBIO hit a ceiling of $13.4 million in Q2 2025 and a floor of -$62.3 million in Q4 2021.
  • Median Net Income towards Common Stockholders over the past 5 years was -$20.6 million (2022), compared with a mean of -$21.8 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 159.57% in 2021 and later soared 200.12% in 2025.
  • Fortress Biotech's Net Income towards Common Stockholders stood at -$62.3 million in 2021, then skyrocketed by 53.56% to -$28.9 million in 2022, then soared by 61.01% to -$11.3 million in 2023, then grew by 14.49% to -$9.7 million in 2024, then skyrocketed by 35.79% to -$6.2 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were -$6.2 million (Q4 2025), $3.7 million (Q3 2025), and $13.4 million (Q2 2025) per Business Quant data.